299 related articles for article (PubMed ID: 11391714)
21. Prognostic significance of p80 and visceral involvement in childhood CD30 anaplastic large cell lymphoma (ALCL).
Massimino M; Spreafico F; Luksch R; Giardini R
Med Pediatr Oncol; 2001 Aug; 37(2):97-102. PubMed ID: 11496346
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL).
Longo G; Fiorani C; Sacchi S; Callea V; Lombardo M; Federico M; Stelitano C; Angrilli F; Vallisa D; Gobbi PG; Ilariucci F; Frassoldati A; Petrini M; Silingardi V
Haematologica; 1999 May; 84(5):425-30. PubMed ID: 10329921
[TBL] [Abstract][Full Text] [Related]
23. The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation.
Kinney MC; Kadin ME
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S56-67. PubMed ID: 9894470
[TBL] [Abstract][Full Text] [Related]
24. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
25. A small cell variant of ALK-positive, CD8-positive anaplastic large cell lymphoma with primary subcutaneous presentation mimicking subcutaneous panniculitis-like T-cell lymphoma.
Wang E; Papalas J; Siddiqi I; Stoecker M; Rehder C; Sebastain S; Burchette J; Huang Q
Pathol Res Pract; 2011 Aug; 207(8):522-6. PubMed ID: 21763080
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous presentation on the eyelid of primary, systemic, CD30+, anaplastic lymphoma kinase (ALK)-negative, anaplastic large-cell lymphoma (ALCL).
Mencía-Gutiérrez E; Gutiérrez-Díaz E; Salamanca J; Martínez-González MA
Int J Dermatol; 2006 Jun; 45(6):766-9. PubMed ID: 16796648
[TBL] [Abstract][Full Text] [Related]
27. Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood.
Hutchison RE; Banki K; Shuster JJ; Barrett D; Dieck C; Berard CW; Murphy SB; Link MP; Pick TE; Laver J; Schwenn M; Mathew P; Morris SW
Ann Oncol; 1997; 8 Suppl 1():37-42. PubMed ID: 9187427
[TBL] [Abstract][Full Text] [Related]
28. Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma?
Fornari A; Piva R; Chiarle R; Novero D; Inghirami G
Hematol Oncol; 2009 Dec; 27(4):161-70. PubMed ID: 19358142
[TBL] [Abstract][Full Text] [Related]
29. Expression of anaplastic lymphoma kinase, tyrosine-phosphorylated STAT3, and associated factors in pediatric anaplastic large cell lymphoma: A report from the children's oncology group.
Nasr MR; Laver JH; Chang M; Hutchison RE
Am J Clin Pathol; 2007 May; 127(5):770-8. PubMed ID: 17439836
[TBL] [Abstract][Full Text] [Related]
30. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis.
Laurent C; Do C; Gascoyne RD; Lamant L; Ysebaert L; Laurent G; Delsol G; Brousset P
J Clin Oncol; 2009 Sep; 27(25):4211-6. PubMed ID: 19636007
[TBL] [Abstract][Full Text] [Related]
31. ALK-negative anaplastic large cell lymphoma with extensive peripheral blood and bone marrow involvements manifested as "leukemic phase".
Lu Y; Zhao X; Wang E; Chen W; Huang Q
Leuk Res; 2010 Apr; 34(4):475-82. PubMed ID: 19695703
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype.
Suzuki R; Kagami Y; Takeuchi K; Kami M; Okamoto M; Ichinohasama R; Mori N; Kojima M; Yoshino T; Yamabe H; Shiota M; Mori S; Ogura M; Hamajima N; Seto M; Suchi T; Morishima Y; Nakamura S
Blood; 2000 Nov; 96(9):2993-3000. PubMed ID: 11049976
[TBL] [Abstract][Full Text] [Related]
33. Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type.
Pileri SA; Pulford K; Mori S; Mason DY; Sabattini E; Roncador G; Piccioli M; Ceccarelli C; Piccaluga PP; Santini D; Leone O; Stein H; Falini B
Am J Pathol; 1997 Apr; 150(4):1207-11. PubMed ID: 9094977
[TBL] [Abstract][Full Text] [Related]
34. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression.
Nakamura S; Shiota M; Nakagawa A; Yatabe Y; Kojima M; Motoori T; Suzuki R; Kagami Y; Ogura M; Morishima Y; Mizoguchi Y; Okamoto M; Seto M; Koshikawa T; Mori S; Suchi T
Am J Surg Pathol; 1997 Dec; 21(12):1420-32. PubMed ID: 9414185
[TBL] [Abstract][Full Text] [Related]
35. Apoptotic rate in peripheral T-cell lymphomas. A study using a tissue microarray with validation on full tissue sections.
Rassidakis GZ; Jones D; Thomaides A; Sen F; Lai R; Cabanillas F; McDonnell TJ; Medeiros LJ
Am J Clin Pathol; 2002 Sep; 118(3):328-34. PubMed ID: 12219774
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials.
Sibon D; Fournier M; Brière J; Lamant L; Haioun C; Coiffier B; Bologna S; Morel P; Gabarre J; Hermine O; Sonet A; Gisselbrecht C; Delsol G; Gaulard P; Tilly H
J Clin Oncol; 2012 Nov; 30(32):3939-46. PubMed ID: 23045585
[TBL] [Abstract][Full Text] [Related]
37. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified.
ten Berge RL; de Bruin PC; Oudejans JJ; Ossenkoppele GJ; van der Valk P; Meijer CJ
Histopathology; 2003 Nov; 43(5):462-9. PubMed ID: 14636272
[TBL] [Abstract][Full Text] [Related]
38. Anaplastic large cell lymphoma: a single institution experience from India.
Lakshmaiah KC; Guruprasad B; Shah A; Kavitha S; Abraham LJ; Govindbabu K; Aruna Kumari BS; Appaji L
J Cancer Res Ther; 2013; 9(4):649-52. PubMed ID: 24518711
[TBL] [Abstract][Full Text] [Related]
39. Anaplastic large cell lymphoma: redefining its morphologic spectrum and importance of recognition of the ALK-positive subset.
Chan JK
Adv Anat Pathol; 1998 Sep; 5(5):281-313. PubMed ID: 10021895
[No Abstract] [Full Text] [Related]
40. CD4 T-helper responses to the anaplastic lymphoma kinase (ALK) protein in patients with ALK-positive anaplastic large-cell lymphoma.
Ait-Tahar K; Barnardo MC; Pulford K
Cancer Res; 2007 Mar; 67(5):1898-901. PubMed ID: 17332315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
